LENSAR (LNSR) Projected to Post Earnings on Thursday

LENSAR (NASDAQ:LNSR) is expected to be issuing its Q2 2025 quarterly earnings data before the market opens on Thursday, August 14th. Analysts expect the company to announce earnings of ($0.08) per share and revenue of $16.55 million for the quarter.

LENSAR (NASDAQ:LNSR) last released its quarterly earnings data on Thursday, May 8th. The company reported ($2.32) EPS for the quarter, missing analysts’ consensus estimates of ($0.16) by ($2.16). LENSAR had a negative net margin of 99.17% and a negative return on equity of 737.30%. The business had revenue of $11.53 million during the quarter, compared to analyst estimates of $13.40 million.

LENSAR Price Performance

NASDAQ LNSR opened at $13.03 on Thursday. The firm’s 50-day moving average is $12.95 and its two-hundred day moving average is $12.92. LENSAR has a 12 month low of $3.50 and a 12 month high of $17.31. The stock has a market capitalization of $153.62 million, a P/E ratio of -2.69 and a beta of 0.50.

Institutional Trading of LENSAR

An institutional investor recently bought a new position in LENSAR stock. Acadian Asset Management LLC bought a new position in shares of LENSAR, Inc. (NASDAQ:LNSR) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 18,243 shares of the company’s stock, valued at approximately $257,000. Acadian Asset Management LLC owned 0.15% of LENSAR as of its most recent filing with the Securities and Exchange Commission (SEC). 40.15% of the stock is owned by institutional investors.

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.